Citadel Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,700
| Closed | -$183K | – | 15653 |
|
|
2023
Q3 | $183K | Buy |
7,700
+2,400
| +45% | +$45.2K | ﹤0.01% | 10061 |
|
|
2023
Q2 | $86K | Buy |
5,300
+4,900
| +1,225% | +$81.2K | ﹤0.01% | 11151 |
|
|
2023
Q1 | $6.96K | Sell |
400
-400
| -50% | -$7.19K | ﹤0.01% | 13770 |
|
|
2022
Q4 | $15K | Buy |
+800
| New | +$15.4K | ﹤0.01% | 13358 |
|
|
2021
Q1 | – | Sell |
-18,500
| Closed | -$337K | – | 13878 |
|
|
2020
Q4 | $337K | Sell |
18,500
-300
| -2% | -$4.76K | ﹤0.01% | 8871 |
|
|
2020
Q3 | $240K | Buy |
18,800
+6,800
| +57% | +$86.9K | ﹤0.01% | 8527 |
|
|
2020
Q2 | $132K | Buy |
+12,000
| New | +$124K | ﹤0.01% | 8831 |
|
|
2017
Q1 | – | Sell |
-10,800
| Closed | -$142K | – | 8195 |
|
|
2016
Q4 | $142K | Buy |
+10,800
| New | +$138K | ﹤0.01% | 6533 |
|
|
2016
Q3 | – | Sell |
-22,500
| Closed | -$268K | – | 7918 |
|
|
2016
Q2 | $268K | Sell |
22,500
-86,800
| -79% | -$1.17M | ﹤0.01% | 5391 |
|
|
2016
Q1 | $1.67M | Buy |
109,300
+103,300
| +1,722% | +$1.57M | ﹤0.01% | 2851 |
|
|
2015
Q4 | $97K | Sell |
6,000
-17,300
| -74% | -$253K | ﹤0.01% | 6730 |
|
|
2015
Q3 | $291K | Buy |
23,300
+16,600
| +248% | +$228K | ﹤0.01% | 5609 |
|
|
2015
Q2 | $111K | Buy |
6,700
+4,300
| +179% | +$69.3K | ﹤0.01% | 6982 |
|
|
2015
Q1 | $38K | Sell |
2,400
-4,300
| -64% | -$71.1K | ﹤0.01% | 7565 |
|
|
2014
Q4 | $104K | Sell |
6,700
-4,700
| -41% | -$68.7K | ﹤0.01% | 6607 |
|
|
2014
Q3 | $157K | Sell |
11,400
-6,300
| -36% | -$95.6K | ﹤0.01% | 5985 |
|
|
2014
Q2 | $284K | Buy |
17,700
+300
| +2% | +$4.75K | ﹤0.01% | 5128 |
|
|
2014
Q1 | $294K | Buy |
17,400
+9,200
| +112% | +$167K | ﹤0.01% | 5050 |
|
|
2013
Q4 | $173K | Sell |
8,200
-3,400
| -29% | -$76.6K | ﹤0.01% | 5169 |
|
|
2013
Q3 | $252K | Buy |
11,600
+2,900
| +33% | +$61.9K | ﹤0.01% | 4540 |
|
|
2013
Q2 | $163K | Buy |
+8,700
| New | +$159K | ﹤0.01% | 4842 |
|
Other funds holding NXGN
Citadel Advisors's NXGN Position: Q4 2023 in Review
Citadel Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 5,571 shares — an estimated $132K sold.
Citadel Advisors first reported a position in NXGN in Q2 2013 and held it in 38 quarters. The position peaked at $9.8M in Q3 2014. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Citadel Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 5,571 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $132K.
- Citadel Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
- Citadel Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $9.8M in Q3 2014.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.